세계의 체외수정 서비스 시장 보고서(2025년)
IVF Services Global Market Report 2025
상품코드 : 1824501
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,469,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,350,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,232,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

체외수정 서비스 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 CAGR 10.3%로 324억 달러로 성장할 것입니다. 예측 기간의 성장은 불임율 상승, 불임 치료 관련 기술 개발, 임신을 돕는 체외수정 서비스 도입 확대, 동성 커플 증가, 불임 치료 클리닉 증가, 가처분 소득 증가, 만혼화 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 유전성 질환을 극복할 수 있는 미토콘드리아 대체 요법의 제공, 불임 치료를 원하는 사람들에게 새로운 기술의 도입과 더 나은 솔루션 제공, 임신 가능성을 높일 수 있는 PGT-A 검진 및 검사 프로그램의 제공, 비용과 시간을 비용과 시간 절감을 위한 인공지능 활용, 블록체인 기반 앱 구현, 안전하고 중단 없는 일정한 배아 관찰을 위한 타임랩스 현미경과 같은 첨단 기술 채택 등이 있습니다.

향후 5년간의 성장률 10.3%는 지난번 예측보다 0.2% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 호주와 벨기에에서 수입되는 배아 배양 장비와 동결보존 배지의 가격을 급등시킴으로써 미국의 불임 치료 접근성을 저해하고, 그 결과 치료 성공률을 낮추고 환자의 생식 의료 비용을 상승시킬 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

체외수정(IVF) 서비스 시장의 성장은 불임율의 증가에 기인합니다. 미국 보건복지부에 따르면, 불임은 12개월 이내에 임신을 할 수 없는 것으로 정의되며, 100쌍의 부부 중 약 12-13쌍이 불임에 시달리고 있습니다. Indian Journal of Community Medicine 저널에 따르면, 인도에만 1,500만-2,000만 명의 불임 환자가 있다고 합니다. 이러한 불임의 증가는 개인을 체외수정 서비스로 이끌며 시장 확대에 기여하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

In vitro fertilization (IVF) is a process of fertilization where an egg is combined with sperm outside the body, in vitro ('in glass'). It is a sophisticated set of treatments intended to improve fertility, address genetic issues, and aid in child conception, primarily used to address infertility.

The main types of cycles in the IVF services market are fresh IVF cycles (non-donor), thawed IVF cycles (non-donor), and donor egg IVF cycles. A fresh IVF cycle is completed using eggs and embryos that have never been frozen. In this process, eggs are extracted and fertilized in the laboratory with semen. Various service providers in the IVF services market include fertility clinics, hospitals, surgical centers, and clinical research institutes. These services find applications in sectors such as fertility clinics, hospitals, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The IVF services market research report is one of a series of new reports from The Business Research Company that provides IVF services market statistics, including IVF services industry global market size, regional shares, competitors with an IVF services market share, detailed IVF services market segments, market trends and opportunities, and any further data you may need to thrive in the IVF services industry. This IVF services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ivf services market size has grown rapidly in recent years. It will grow from $19.57 billion in 2024 to $21.9 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to increased increasing prevalence of pcos condition, increased cases of the premature ovarian failure, increasing rate of male infertility and insurance coverages to ivf procedures.

The ivf services market size is expected to see rapid growth in the next few years. It will grow to $32.4 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to rising infertility rate, technological developments regarding fertility treatment, growing adoption of IVF services to aid in pregnancy, rising number of same sex couples, increase in number of fertility clinics, rise in disposable income and late parenthood. Major trends in the forecast period include providing mitochondrial replacement therapies to potentially overcome genetic disorders, adopting new technologies and provide and better solutions to people seeking for fertility treatments, offering PGT-A screening or testing program to potentially increase the chances of pregnancy, using artificial intelligence to reduce costs and time, implement blockchain based apps and adopting advanced technologies such as time-lapse microscopy for safe, uninterrupted and constant embryo observation.

The forecast of 10.3% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. fertility treatment access by inflating prices of embryology lab equipment and cryopreservation media imported from Australia and Belgium, resulting in reduced treatment success rates and higher reproductive medicine costs for patients. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the in vitro fertilization (IVF) services market is attributed to the increasing infertility rate. Infertility, defined as the inability to conceive within 12 months, affects around 12 to 13 couples in 100, according to the US Department of Health and Human Services. The Indian Journal of Community Medicine reports 15 to 20 million infertility cases in India alone. This rise in infertility has led individuals to turn to IVF services, contributing to the expansion of the market.

Government initiatives aimed at improving access to fertility treatments are expected to drive the growth of the IVF services market. Governments are undertaking specific actions, policies, or projects to address fertility-related issues. An example is the New South Wales Affordable IVF Program, where the New South Wales government committed $80 million from 2022-23 to 2025-26 to enhance access to affordable fertility treatments.

The application of platelet-rich plasma (PRP) is a recent technique increasingly employed to enhance the success rate of IVF, particularly in patients with recurrent implantation failures. PRP is utilized alongside IVF to improve egg quality, uterine lining thickness, and endometrial receptivity, primarily for cases of recurrent implantation failure. Studies show that women treated with PRP experience significant improvements in Follicle-Stimulating Hormone (FSH), Anti-Mullerian Hormone (AMH), and Antral Follicle Count (AFC), thereby aiding fertility.

Major companies in the IVF services sector are innovating by incorporating artificial intelligence (AI) into IVF treatments. The use of AI in IVF has the potential to transform fertility care by providing personalized, data-driven insights for clinicians and patients. For instance, Alife Health, a US-based healthcare company, launched new artificial intelligence software in October 2022 to advance IVF treatment outcomes, reduce costs, and support clinical decision-making during crucial stages of the IVF process.

In July 2023, BPEA EQT, a Hong Kong-based investment company, acquired a 60% stake in Indira IVF for approximately $657 million. This strategic move aims to strengthen Indira IVF's presence across India, explore expansion into neighboring markets, and enhance accessibility to fertility services and reproductive health for couples. Indira IVF is an India-based company specializing in providing IVF services.

Major companies operating in the IVF services market include Monash IVF Group, Virtus Health Limited, Chelsea and Westminster Hospital NHS Foundation Trust, Genea Limited, Boston IVF, IVF Spain, Morpheus Life Sciences Pvt. Ltd., Dunya IVF, Cardone Reproductive Medicine & Infertility LLC, Cloudnine Fertility, Sun Pharmaceuticals Industries Ltd., Cadila Healthcare Ltd., Trivector Origio Scientific, Lab IVF Asia Pte Ltd., LG Life Sciences, Bourn Hall Clinic, Southend Fertility, Indira IVF, Pearl Women Hospital & Yash IVF Center, Corion Fertility Clinic, Origin International Fertility Center, Apollo Hospitals Dhaka, Australian Concept Infertility Medical Center (ACIMC), Bahosi Fertility Centre, Bloom Fertility and Healthcare, Bumrungrad International Hospital, Center for Advanced Reproductive Medicine and Infertility, CHA Fertility Center, United Family Healthcare, The New Hope Fertility Center, Melinda Hospital, Bocah Indonesia, Daya Medika, Clinique de la Muette, Klinikum Stuttgart, DRK Kliniken Berlin, University Medical Center Freiburg, CREATE Fertility, The Centre for Reproductive & Genetic Health, The Bridge Centre, Next Generation Clinic, UNICA Clinic - Prague, Repromeda s.r.o., MD Medical Group, Univfy, Progyny, Advantia Health, Maven Clinic, Future Family, Instituto de Fertilidad Humana, The Colombian Center for Fertility and Sterility, NMC Health, Dubai Gynecology and Fertility Centre, New Life Medical Centre, Cairo Fertility Centre (Egypt), Queens Fertility Centre (Egypt), BPE Partners, Cleopatra Hospitals Group (CHG)

Western Europe was the largest region in the IVF services market in 2024. North America was the second largest region in global IVF services market share. The regions covered in the ivf services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the IVF services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The IVF services market includes revenues earned by entities by providing services such as conventional insemination services, and intracytoplasmic sperm injection services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

IVF Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ivf services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for ivf services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ivf services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. IVF Services Market Characteristics

3. IVF Services Market Trends And Strategies

4. IVF Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global IVF Services Growth Analysis And Strategic Analysis Framework

6. IVF Services Market Segmentation

7. IVF Services Market Regional And Country Analysis

8. Asia-Pacific IVF Services Market

9. China IVF Services Market

10. India IVF Services Market

11. Japan IVF Services Market

12. Australia IVF Services Market

13. Indonesia IVF Services Market

14. South Korea IVF Services Market

15. Western Europe IVF Services Market

16. UK IVF Services Market

17. Germany IVF Services Market

18. France IVF Services Market

19. Italy IVF Services Market

20. Spain IVF Services Market

21. Eastern Europe IVF Services Market

22. Russia IVF Services Market

23. North America IVF Services Market

24. USA IVF Services Market

25. Canada IVF Services Market

26. South America IVF Services Market

27. Brazil IVF Services Market

28. Middle East IVF Services Market

29. Africa IVF Services Market

30. IVF Services Market Competitive Landscape And Company Profiles

31. IVF Services Market Other Major And Innovative Companies

32. Global IVF Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The IVF Services Market

34. Recent Developments In The IVF Services Market

35. IVF Services Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기